Laura Waters
4PUBLICATIONS
79CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 22, 2025
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer.Kristina Drizyte-Miller, Lars D Engstrom, Jeffrey A Klomp
|Jan 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial.Marcelo V Negrao, Alvaro G Paula, David Molkentine
|Jun 21, 2024
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading.Niranjan Sudhakar, Larry Yan, Fadia Qiryaqos
|Aug 08, 2023
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer.Lars D Engstrom, Ruth Aranda, Laura Waters
Pageof 1
Frequent Collaborators
4 joint publications
Lars Engstrom
4 joint publications
James G Christensen
4 joint publications
Peter Olson
4 joint publications
Jill Hallin
4 joint publications
David M Briere
3 joint publications
Laura Hover
3 joint publications
Andrew Calinisan
2 joint publications
Allan Hebbert
2 joint publications
Laura Vegar
2 joint publications
Vickie Bowcut
